SUMMARY The accuracy of rest and exercise radionuclide angiocardiography (RNA) and exercise treadmill testing (ETT) for diagnosis of three-vessel or left main coronary artery disease (extensive CAD) was determined in 544 patients. ETT and RNA sensitivities were similar (88% vs 92%, NS), but ETT was more specific than RNA (46% vs 34%, p < 0.01). The prevalence of extensive CAD in patients with a positive treadmill (41 %) increased only 3% when the RNA was also positive. However, in the 292 patients with a negative or indeterminate ETT, a positive RNA increased this prevalence from 16% to 23%, while a negative RNA decreased this prevalence to 5%. These results support the initial use of ETT followed by RNA if the treadmill is negative or indeterminate for diagnosis in a population with a high prevalence of extensive CAD. This approach separates patients into subgroups with a high or low probability of extensive CAD.
SURVIVAL in patients with coronary artery disease (CAD) has been related to the number of diseased coronary vessels and to the presence of significant left main coronary artery stenosis. X-The identification of patients with a high probability of three-vessel or left main disease is an important goal of noninvasive testing. Exercise-induced left ventricular functional abnormalities appear to result from ischemia and can be (50%) of these 3005 patients. Seventy-eight of these 1495 patients were excluded from this investigation because of previous cardiac surgery or concomitant congenital or significant valvular heart disease. Rest and exercise RNA studies were performed within 3 months of cardiac catheterization and arteriography in 544 of the remaining 1417 patients. Data from these 544 patients were obtained from the Duke University Medical Center computerized information storage and retrieval system. '2 Cardiac catheterization included right-and left-heart pressure measurements, biplane left ventriculograms and selective coronary arteriograms in multiple views of both the right and left coronary systems. Arteriograms were interpreted in conference by two or more experienced cardiologists who were not investigators in this study. A 75% or greater narrowing of the luminal diameter was required to diagnose significant CAD in any coronary vessel, including the left main coronary artery. Stenoses of less than 75% of the vessel diameter were considered insignificant. Coronary arteries were considered normal if no areas of stenosis were apparent.
Exercise Treadmill Test Technique
Exercise treadmill testing was performed using the Bruce graded multistage protocol.'3 Exercise end points were moderate chest pain, severe fatigue or dyspnea, claudication, serious arrhythmias, marked ST-segment changes on the ECG or achievement of 85% of the maximal predicted heart rate (220 -age).
Positive ST-segment changes were defined as: (1) horizontal or downsloping ST-segment depression of 0.1 mV or greater persisting at least 0.08 second in the absence of preexisting ST-segment abnormalities; (2) ST-segment elevation of 0.1 mV or more than in the control tracing in any lead except aVR; (3) in the presence of ST-segment depression of 0.05 mV or more in the control tracing, additional depression equal to or greater than 0.2 mV was required for the test to be interpreted as positive. The ETT was negative only when the patient achieved 85% of the maximal predicted heart rate and failed to develop any positive STsegment changes. The test was indeterminate when no positive ST-segment changes occurred but the patient failed to achieve 85% of the maximal predicted heart rate. Other reasons for an indeterminate test included left bundle branch block or the development of a serious arrhythmia during exercise.
Since exercise duration during ETT is considered to provide additional diagnostic information,'4 the effect of incorporating the maximum stage into the definition of a positive ETT was examined. No increase in the sum of ETT sensitivity and specificity was obtained and, therefore, the positive ETT definition used in this study did not incorporate the exercise duration.
Radionuclide Angiocardiographic Technique RNA studies were performed at rest and during exercise as previously described" with patients in the upright, sitting position on a bicycle ergometer (Fitron, Lumex Inc.), using a multicrystal gamma camera (System Seventy-Seven, Baird, Inc.) positioned anterior to the precordium. The rest RNA was performed by injecting a 15-mCi bolus of technetium-99m pertechnetate and recording counts at 25-msec intervals for 30 seconds. Exercise was then begun at a work load of 200 kilopond-meter (kpm)/min and was increased by 100 kpm/min each minute. The exercise RNA was obtained upon occurrence of any of these end points: pain suggestive of myocardial ischemia, ECG evidence of ischemia, severe fatigue or dyspnea, or achievement of 85% of the maximal predicted heart rate.
Measurements determined included left ventricular ejection fraction (LVEF), end-diastolic volume and end-systolic volume (ESV). These measurements have been shown to be accurate and reproducible.'' 16 Regional wall motion was assessed qualitatively using static and cinematic images of a representative cardiac cycle. An exercise-induced wall motion abnormality was defined as the appearance of a wall motion abnormality not present at rest or an increase in the severity or extent of a wall motion abnormality present at rest.
The RNA was considered abnormal if the resting LVEF was less than 0.50, ESV increased more than 20 ml during exercise, exercise LVEF was more than 0.05 below the predicted value, or an exercise-induced wall motion abnormality developed. These criteria were initially developed in our laboratory to identify patients with a 75% or greater stenosis of one or more coronary arteries. "I Since different criteria might better identify patients with three-vessel or left main disease, the previously described methods of defining optimal criteria were repeated to identify patients with anatomically extensive CAD. No alternative set of criteria increased the sum of RNA sensitivity and specificity; therefore, the above criteria initially published by our laboratory were used to recognize anatomically extensive CAD.
Determination of RNA and ETT Diagnostic Accuracy
The diagnostic accuracy of RNA was determined by applying the RNA criteria to the entire population and to selected subgroups of the population. The diagnostic accuracy of the ETT was assessed by calculating its sensitivity and specificity in patients with positive or negative treadmill results. Combined use of the RNA and the ETT was evaluated by determining the prevalence of three-vessel or left main CAD in patients grouped by the RNA and ETT results and by calculating the sensitivity and specificity of combinations of both tests.
Mortality data were obtained at 6 months and at yearly intervals after the initial evaluation. These data were obtained by staff cardiologists during a clinic visit or by a research associate by telephone. Follow-up was 97% complete.
Statistical Analysis
Differences between groups were assessed for significance by chi-square analysis. In all instances where chi-square analysis was used, p values have been included in the text. Ap value less than 0.01 was considered significant.
Results
Patients studied by RNA main disease only, the sensitivity was 91% and the specificity was 38%. The ETT was 84% sensitive and 61% specific for the diagnosis of two-vessel, threevessel or left main CAD. Application of the ETT for the diagnosis of any significant CAD resulted in a sensitivity of 77% and a specificity of 76% (table 3) . Comparable ETT sensitivities and specificities were obtained when patients without a previous myocardial infarction documented by characteristic ECG or enzyme changes or both were considered (table 4). Similar ETT sensitivities and specificities were observed in patients with a resting LVEF greater than or equal to 0.50 and no resting wall motion abnormalities.
Diagnostic Accuracy of the RNA An abnormal radionuclide result was based solely upon a resting LVEF less than 0.50 in 45 of the 544 patients (8.3%). In 13 of the 544 patients (2.4%), the only abnormality observed during RNA was the development of an exercise-induced wall motion abnormality. Overall, an exercise-induced wall motion abnormality was present in 236 of the 544 patients (43%).
Applying the abnormal RNA criteria to the entire population of 544 patients resulted in a sensitivity of 92% and a specificity of 34% for the diagnosis of three-vessel or left main CAD. When the RNA was applied for the diagnosis of left main coronary artery disease only, the sensitivity was 83% and the specificity was 27%. The RNA was 88% sensitive and 43% specific for the diagnosis of two-vessel, three-vessel or left main disease. Application of the RNA for the diagnosis of significant CAD yielded a sensitivity of 85% and a specificity of 59% (table 5) . The RNA sensitivities and specificities were similar in patients without a previous myocardial infarction (table 6) and in patients with a normal resting LVEF and no resting wall motion abnormalities.
Excluding patients who did not achieve an adequate exercise end point during RNA did not significantly alter the sensitivity (91% vs 92%) or the specificity (32% vs 34%) of the RNA for the diagnosis of anatomically extensive CAD (NS). Three-vessel or left main disease was less prevalent in patients who achieved 85% of their target heart rate (15%) and more prevalent in patients who developed angina (39%) or ECG ischemic changes (51 %) during the RNA than in the overall population (28%).
Patients who took propranolol within 24 hours of the RNA had a higher prevalence of anatomically extensive CAD (33%) than patients who did not (26%). Despite this higher disease prevalence, the RNA was less sensitive (84% vs 94%) and less specific (31% vs 35%) for the diagnosis of severe CAD in patients who took propranolol. Excluding the 96 patients who were taking propranolol at the time of the RNA did not significantly change the sensitivity (94% vs 92%) or the specificity (35% vs 34%) of the RNA (NS).
Comparison of RNA and ETT
The RNA was more sensitive than the ETT (p = 0.008) for the diagnosis of significant CAD, but both tests were equally sensitive (NS) for the diagnosis of all other degrees of CAD. The ETT was more specific than the RNA (p < 0.01) for the diagnosis of all degrees of CAD.
In the 544 patients studied, the ETT was positive in 252, negative in 141 and indeterminate in 151 patients. The RNA was positive in 398 patients and negative in 146 patients. The prevalence of three-vessel or left main CAD was 41% in patients with a positive ETT, 35% in patients with a positive RNA and 44% in patients with both a positive ETT and a positive RNA. The prevalence of three-vessel or left main disease was 10% in patients with a negative ETT, 8% in patients with a negative RNA and 0% in patients with both tests group of patients evaluated for suspected coronary disease.
The study population had a lower prevalence of NYHA class IV angina, progressive angina or a history of congestive heart failure than the 3005 patients who underwent cardiac catheterization. This difference reflects the fact that patients with more severe CAD undergo cardiac catheterization directly without prior exercise stress testing by ETT or RNA. Since no significant differences were found between the study group and the 1495 patients undergoing ETT in addition to cardiac catheterization, the study population appears representative of all patients undergoing exercise stress testing for suspected 'coronary artery disease at this institution.
The sensitivity and specificity data show that the ETT and the RNA are comparable for diagnosis of differing anatomic extents of coronary artery disease. The RNA is more sensitive (85% vs 77%) but less specific (59% vs 76%) than the ETT in recognizing patients with a 75% or greater stenosis of one or more coronary arteries. This agrees with our previous report," and the present study extends this analysis to more severe degrees of coronary arterial involvement. The RNA is as'sensitive as, but less specific than, the ETT for the diagnosis of two-vessel or greater CAD, of three-vessel or left main disease, and of left main coronary disease only. The low RNA specificity has been noted previously, and the reason for an abnormal left ventricular response to exercise in patients with chest pain and normal coronary arteriograms is an important topic for further investigation. In the present study, the low RNA specificity was largely due to abnormal tests in patients with one-or two-vessel CAD. The RNA is also significantly less specific in women" I and the present study population included 148 (27%) women Preliminary follow-up data suggest that the RNA may be more effective than the ETT in assessing prognosis. Twenty of the 29 patients (69%) who died after initial evaluation had a positive ETT, while 28 of these patients (97%) had a positive RNA (chi-square = 7.33, p = 0.006). The majority of deaths occurred in patients with a positive ETT and a positive RNA, indicating that this subgroup is at higher risk for subsequent death. Nine deaths (31%) occurred in patients with a negative or indeterminate ETT, and a positive RNA identified eight of'these nine patients. Sequential use of the ETT and the RNA would have identified 28 of the 29 patients who subsequently died as having probable severe CAD. The one patient missed by this approach had'insignificant CAD and died 1 day after urgent myocardial revascularization performed for preinfarction angina. Coronary artery spasm was probably a significant factor in this death. These preliminary follow-up data further support the sequential use of the EFT and the RNA in the evaluation of a population with a high prevalence of anatomically extensive CAD.
